Ilorasertib is an Orally Active ATP-Competitive Multitargeted Kinase Inhibitor
Aurora kinases are key regulators of mitosis that overexpress in many cancer types. Ilorasertib (ABT-348) is a potent inhibitor of all three Aurora kinases, although it has greater activity versus…